Literature DB >> 31997849

Joint Region and Nucleus Segmentation for Characterization of Tumor Infiltrating Lymphocytes in Breast Cancer.

Mohamed Amgad1,2, Anindya Sarkar2, Chukka Srinivas2, Rachel Redman3, Simrath Ratra2, Charles J Bechert3, Benjamin C Calhoun4, Karen Mrazeck4, Uday Kurkure2, Lee Ad Cooper1,5,6, Michael Barnes3.   

Abstract

Histologic assessment of stromal tumor infiltrating lymphocytes (sTIL) as a surrogate of the host immune response has been shown to be prognostic and potentially chemo-predictive in triple-negative and HER2-positive breast cancers. The current practice of manual assessment is prone to intra- and inter-observer variability. Furthermore, the inter-play of sTILs, tumor cells, other microenvironment mediators, their spatial relationships, quantity, and other image-based features have yet to be determined exhaustively and systemically. Towards analysis of these aspects, we developed a deep learning based method for joint region-level and nucleus-level segmentation and classification of breast cancer H&E tissue whole slide images. Our proposed method simultaneously identifies tumor, fibroblast, and lymphocyte nuclei, along with key histologic region compartments including tumor and stroma. We also show how the resultant segmentation masks can be combined with seeding approaches to yield accurate nucleus classifications. Furthermore, we outline a simple workflow for calibrating computational scores to human scores for consistency. The pipeline identifies key compartments with high accuracy (Dice= overall: 0.78, tumor: 0.83, and fibroblasts: 0.77). ROC AUC for nucleus classification is high at 0.89 (micro-average), 0.89 (lymphocytes), 0.90 (tumor), and 0.78 (fibroblasts). Spearman correlation between computational sTIL and pathologist consensus is high (R=0.73, p<0.001) and is higher than inter-pathologist correlation (R=0.66, p<0.001). Both manual and computational sTIL scores successfully stratify patients by clinical progression outcomes.

Entities:  

Keywords:  Tumor infiltrating lymphocytes; computational pathology; convolutional networks; deep learning

Year:  2019        PMID: 31997849      PMCID: PMC6988758          DOI: 10.1117/12.2512892

Source DB:  PubMed          Journal:  Proc SPIE Int Soc Opt Eng        ISSN: 0277-786X


  11 in total

1.  Spatial Characterization of Tumor-Infiltrating Lymphocytes and Breast Cancer Progression.

Authors:  Danielle J Fassler; Luke A Torre-Healy; Rajarsi Gupta; Alina M Hamilton; Soma Kobayashi; Sarah C Van Alsten; Yuwei Zhang; Tahsin Kurc; Richard A Moffitt; Melissa A Troester; Katherine A Hoadley; Joel Saltz
Journal:  Cancers (Basel)       Date:  2022-04-26       Impact factor: 6.575

2.  Specific in situ inflammatory states associate with progression to renal failure in lupus nephritis.

Authors:  Rebecca Abraham; Madeleine S Durkee; Junting Ai; Margaret Veselits; Gabriel Casella; Yuta Asano; Anthony Chang; Kichul Ko; Charles Oshinsky; Emily Peninger; Maryellen L Giger; Marcus R Clark
Journal:  J Clin Invest       Date:  2022-07-01       Impact factor: 19.456

3.  An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer.

Authors:  Balazs Acs; David L Rimm; Yalai Bai; Kimberly Cole; Sandra Martinez-Morilla; Fahad Shabbir Ahmed; Jon Zugazagoitia; Johan Staaf; Ana Bosch; Anna Ehinger; Emma Nimeus; Johan Hartman
Journal:  Clin Cancer Res       Date:  2021-06-04       Impact factor: 12.531

4.  Deep-Learning-Based Characterization of Tumor-Infiltrating Lymphocytes in Breast Cancers From Histopathology Images and Multiomics Data.

Authors:  Zixiao Lu; Siwen Xu; Wei Shao; Yi Wu; Jie Zhang; Zhi Han; Qianjin Feng; Kun Huang
Journal:  JCO Clin Cancer Inform       Date:  2020-05

5.  Deep learning-based image analysis methods for brightfield-acquired multiplex immunohistochemistry images.

Authors:  Danielle J Fassler; Shahira Abousamra; Rajarsi Gupta; Chao Chen; Maozheng Zhao; David Paredes; Syeda Areeha Batool; Beatrice S Knudsen; Luisa Escobar-Hoyos; Kenneth R Shroyer; Dimitris Samaras; Tahsin Kurc; Joel Saltz
Journal:  Diagn Pathol       Date:  2020-07-28       Impact factor: 2.644

6.  Human-interpretable image features derived from densely mapped cancer pathology slides predict diverse molecular phenotypes.

Authors:  James A Diao; Jason K Wang; Wan Fung Chui; Andrew H Beck; Hunter L Elliott; Amaro Taylor-Weiner; Victoria Mountain; Sai Chowdary Gullapally; Ramprakash Srinivasan; Richard N Mitchell; Benjamin Glass; Sara Hoffman; Sudha K Rao; Chirag Maheshwari; Abhik Lahiri; Aaditya Prakash; Ryan McLoughlin; Jennifer K Kerner; Murray B Resnick; Michael C Montalto; Aditya Khosla; Ilan N Wapinski
Journal:  Nat Commun       Date:  2021-03-12       Impact factor: 14.919

7.  Deep Learning-Based Mapping of Tumor Infiltrating Lymphocytes in Whole Slide Images of 23 Types of Cancer.

Authors:  Shahira Abousamra; Rajarsi Gupta; Le Hou; Rebecca Batiste; Tianhao Zhao; Anand Shankar; Arvind Rao; Chao Chen; Dimitris Samaras; Tahsin Kurc; Joel Saltz
Journal:  Front Oncol       Date:  2022-02-16       Impact factor: 6.244

Review 8.  Artificial intelligence and digital pathology: Opportunities and implications for immuno-oncology.

Authors:  Faranak Sobhani; Ruth Robinson; Azam Hamidinekoo; Ioannis Roxanis; Navita Somaiah; Yinyin Yuan
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2021-02-06       Impact factor: 11.414

Review 9.  Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.

Authors:  Mohamed Amgad; Elisabeth Specht Stovgaard; Eva Balslev; Jeppe Thagaard; Weijie Chen; Sarah Dudgeon; Ashish Sharma; Jennifer K Kerner; Carsten Denkert; Yinyin Yuan; Khalid AbdulJabbar; Stephan Wienert; Peter Savas; Leonie Voorwerk; Andrew H Beck; Anant Madabhushi; Johan Hartman; Manu M Sebastian; Hugo M Horlings; Jan Hudeček; Francesco Ciompi; David A Moore; Rajendra Singh; Elvire Roblin; Marcelo Luiz Balancin; Marie-Christine Mathieu; Jochen K Lennerz; Pawan Kirtani; I-Chun Chen; Jeremy P Braybrooke; Giancarlo Pruneri; Sandra Demaria; Sylvia Adams; Stuart J Schnitt; Sunil R Lakhani; Federico Rojo; Laura Comerma; Sunil S Badve; Mehrnoush Khojasteh; W Fraser Symmans; Christos Sotiriou; Paula Gonzalez-Ericsson; Katherine L Pogue-Geile; Rim S Kim; David L Rimm; Giuseppe Viale; Stephen M Hewitt; John M S Bartlett; Frédérique Penault-Llorca; Shom Goel; Huang-Chun Lien; Sibylle Loibl; Zuzana Kos; Sherene Loi; Matthew G Hanna; Stefan Michiels; Marleen Kok; Torsten O Nielsen; Alexander J Lazar; Zsuzsanna Bago-Horvath; Loes F S Kooreman; Jeroen A W M van der Laak; Joel Saltz; Brandon D Gallas; Uday Kurkure; Michael Barnes; Roberto Salgado; Lee A D Cooper
Journal:  NPJ Breast Cancer       Date:  2020-05-12

10.  High expression of MKK3 is associated with worse clinical outcomes in African American breast cancer patients.

Authors:  Xuan Yang; Mohamed Amgad; Lee A D Cooper; Yuhong Du; Haian Fu; Andrey A Ivanov
Journal:  J Transl Med       Date:  2020-09-01       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.